According to the latest report by IMARC Group, titled “Acute Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033,” the 7 major acute pain markets are expected to grow at a CAGR of 8.3% during 2023-2033. Acute pain refers to a sudden and intense sensation of discomfort or distress that is usually associated with a specific injury, medical condition, or surgical procedure. It occurs suddenly as compared to chronic pain, which persists over an extended period. It serves as a crucial physiological response and as a protective mechanism that alerts the body about potential harm or injury. It is generally sharp and specified pain that encourages individuals to take immediate actions to alleviate the underlying cause and prevent further damage. It lasts over a short period of time and can cause swelling, redness, and stiffness and limits the range of motion, inflammation, and emotional distress. Besides this, it can be treated through over-the-counter (OTC) medications, physical therapy, topical analgesics, rest and immobilization, injections, and cold and heat therapy.
At present, the increasing prevalence of surgical procedures and medical interventions among individuals represents one of the major factors influencing the market positively. Moreover, the rising adoption of pain management solutions that enhance patient outcomes and improve the quality of life is strengthening the growth of the market. Apart from this, the growing demand for creams, gels, or patches that contain analgesic ingredients to treat pain among individuals is offering a positive market outlook. In line with this, the rising development of personalized therapeutic approaches for acute pain management is contributing to the growth of the market. Besides this, the increasing focus on optimizing pain control to improve patient recovery, reduce hospital stays, and mitigate the risk of complications is offering lucrative growth opportunities to industry investors. In addition, there is a rise in the demand for cost-effective, safe, and highly efficient pain management solutions among the masses. This, coupled with the increasing incidence of chronic diseases among individuals, is bolstering the growth of the market. Furthermore, the rising adoption of patient-centered care approaches by healthcare providers is supporting the growth of the market.
- Region-wise, the market has been classified into the United States, EU5 (Germany, France, the United Kingdom, Italy, and Spain), and Japan. The United States has the largest patient population for acute pain and represents the largest market for its treatment among the seven major markets.
- This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for acute pain.
- The study also offers a thorough overview of the treatment practices for acute pain, the share of specific therapies, and the performance of key market players.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800